Working in tandem
A two-drug therapy that promises to cure stomach ulcers and prevent their recurrence has been approved by the US Food and Drug Administration. Under the newly approved regimen, patients will take the existing ulcer drug Prilosec in conjunction with an antibiotic called Biaxin for 14 days, then continue to take Prilosec for an additional 13 days. Since the high stomach acid concentration found in most ulcer patients can break down the antibiotic ifitis taken by itself, the Prilosec is used to abate the acid, so the Biaxin can kill the ulcer bacteria, Helicobacter pylori. Tests show that the combination healed almost 90 per cent of ulcers and eradicated the H pylori infection by 64 per cent.
Related Content
- Development of coal blocks allocated to power sector: Standing Committee on Energy (2020-21)
- Waste segregation at source is the key
- Admn gears up to curb dengue
- The Cigarette and Other Tobacco Products (Packaging and Labelling) Amendment Rules, 2014: Committee on Subordinate Legislation (2015-16)
- The Convention on Biological Diversity and the Nagoya Protocol: intellectual property implications
- India’s largest strategic philanthropy event,to bring global business and social leaders together toempower 113 million adolescent girls in India